Correction

The Long and Short of Bone Therapy

N Engl J Med 2006; 355:638August 10, 2006

Article

The Long and Short of Bone Therapy (Editorial, N Engl J Med 2006:354;860 - 863) . On page 860, the sentence that begins on line 3 of the second paragraph should have read, “In this issue of the Journal, from a study that was sponsored, designed, and analyzed by Amgen, McClung et al.³ report on the safety and efficacy of various doses of denosumab (formerly known as AMG 162), a fully human monoclonal antibody to the receptor activator of nuclear factor-κB (RANK) ligand (RANKL),” not “a humanized monoclonal antibody,” as printed.